Dr. Uwe-Peter Schobel

Provides global executive leadership for clinical validation, in-market medical operations, and medical risk management across the Siemens Healthineers Diagnostics portfolio. Cornerstone of enterprise execution system—ensuring that medical value propositions are translated into robust regulatory validation strategies, delivered with predictable execution, and sustained through safe, effective product performance in the field.

Led global Medical Affairs organizations across Germany and the U.S., advaned clinical evidence generation, operational excellence, and transformation to enable successful product development and globally aligned regulatory outcomes

Lead cross-functional development and launch initiatives for diagnostic systems, aligning regulatory strategy, resource planning, and executive governance.

Led internal and external clinical evaluations of new and enhanced IVD products (reagents, analyzers, software, and test applications) while developing clinical evidence strategies and executing multicenter, cross-regional validation studies to ensure safe and effective products

Directed the development, validation, and launch of innovative multiparameter fluorescence and ELISA-based diagnostic assays for infectious disease diagnostics, driving assay automation, managing CE marking requirements, and advancing intellectual property through key patent filings

Developed and validated online HPLC MS–coupled receptor/enzyme based assays for high resolution screening of complex natural plant extracts libraries for bioactive compounds.

Physical Chemistry, Analytical Chemistry